<DOC>
	<DOCNO>NCT02416115</DOCNO>
	<brief_summary>Postoperative nausea vomiting ( PONV ) one undesirable complication general anesthesia , may lead increase hospital stay health care cost . The risk factor PONV include sex ( female population ) , nonsmoking status , past history motion sickness and/or previous PONV , duration anesthesia surgical type ( particular gynecologic surgery ) postoperative use opioids . The overall incidence PONV report 30 % considerable variability , increase 69 % - 80 % woman undergo gynecologic surgery general anesthesia morphine-patient control analgesia ( PCA ) . Serotonin receptor antagonist ( 5-HT3 ) suggest one first line therapy prevent PONV efficacy side effect compare antiemetic . However , despite use treatment , incidence PONV report 48 % 50 % . Naloxone drug use counter effect opioid . It find administration low dose naloxone prevents opioid side effect nausea pruritus without affect analgesia opioid requirement patient receive morphine PCA . It report use two antiemetic act different mechanism well prevent PONV monotherapy . Therefore , prospective , randomize , control study design investigate antiemetic efficacy combination ramosetron premixture naloxone morphine PCA gynecologic surgery .</brief_summary>
	<brief_title>Anti Emetic Efficacy Combination Ramosetron Premixture Naloxone With Patient-controlled Analgesia</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<mesh_term>Antiemetics</mesh_term>
	<mesh_term>Emetics</mesh_term>
	<criteria>Nonsmoking woman ( ASA physical status I II ) schedule gynecologic surgery general anesthesia postoperative analgesia PCA device include know hypersensitivity study medication ; use antiemetic within 24 hour surgery ; presence gastrointestinal , renal , hepatic , psychiatric disease .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>PONV</keyword>
	<keyword>ramosetron</keyword>
	<keyword>naloxone</keyword>
</DOC>